20th World Congress of Basic and Clinical Pharmacology 2026 (WCP2026)

活动简介:

Novotech will be attending WCP2026, where researchers, clinicians, industry leaders, and drug development professionals from around the world will come together to discuss the latest advances in pharmacology and therapeutics.

Our team looks forward to meeting with sponsors and industry colleagues to discuss translational planning, toxicology, first-in-human studies, regulatory considerations, and early clinical development across Australia, Asia-Pacific, and other regions.

As new therapies continue to move from discovery into clinical development, these conversations play an important role in helping sponsors make informed decisions about development strategy, study planning, and regional opportunities.

Novotech Attendees:

• Felicity Grzemski, Toxicology Director, Drug Development Consulting
• Carolyn Luscombe, Therapeutic Strategy Manager, Therapeutic Strategy

Visit Booth #6 or request a meeting through the form on this page to discuss your upcoming development plans.